Volitionrx (VNRX) Net Cash Flow Growth (5y) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Volitionrx | 101.83 Mn | 99.36 Mn | -1.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 19.07% |
| Sep 30, 2025 | -81.02% |
| Jun 30, 2025 | -15.68% |
| Mar 31, 2025 | 34.71% |
| Dec 31, 2024 | -8.56% |
| Sep 30, 2024 | -37.00% |
| Jun 30, 2024 | -35.60% |
| Mar 31, 2024 | -38.38% |
| Dec 31, 2023 | 38.96% |
| Sep 30, 2023 | -32.09% |
| Jun 30, 2023 | 42.14% |
| Mar 31, 2023 | -17.00% |
| Dec 31, 2022 | -7.80% |
| Sep 30, 2022 | 30.78% |
| Jun 30, 2022 | -29.05% |
| Mar 31, 2022 | 24.54% |
| Dec 31, 2021 | -17.75% |
| Sep 30, 2021 | -20.08% |
| Jun 30, 2021 | -16.64% |
| Mar 31, 2021 | 4.13% |
| Dec 31, 2020 | -12.37% |
| Sep 30, 2020 | 15.41% |
| Jun 30, 2020 | 48.90% |
| Mar 31, 2020 | -21.03% |
| Dec 31, 2019 | -52.95% |
| Sep 30, 2019 | 4.98% |
| Jun 30, 2019 | 34.05% |
| Mar 31, 2019 | 7.93% |
| Dec 31, 2018 | -57.26% |
| Sep 30, 2018 | 76.85% |
| Jun 30, 2018 | -56.00% |
| Mar 31, 2018 | 156.27% |
| Dec 31, 2017 | -133.35% |
| Sep 30, 2017 | -113.17% |
| Jun 30, 2017 | -65.47% |
| Mar 31, 2017 | -92.53% |
| Dec 31, 2016 | 76.24% |
| Sep 30, 2016 | -37.30% |
| Jun 30, 2016 | -52.47% |
| Mar 31, 2016 | 85.12% |